Arthur F Ryan Regeneron Pharmaceuticals, Inc. (REGN) insider trading activity

REGN Quotes by TradingView

Arthur F Ryan is Director of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 17,582 shares of REGN, which is worth approximately $13.1 Million. The most recent transaction as insider was on Oct 03, 2022, when has been sold 100 shares (Common Stock) at a price of $721.63 per share, resulting in proceeds of $72,163. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.6K
1.13% 3M change
5.2% 12M change
Total Value Held $13.1 Million

ARTHUR F RYAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 03 2022
SELL
Open market or private sale
$72,163 $721.63 p/Share
100 Reduced 0.51%
19,482 Common Stock
Sep 06 2022
SELL
Open market or private sale
$58,203 $582.03 p/Share
100 Reduced 0.51%
19,582 Common Stock
Aug 04 2022
SELL
Bona fide gift
-
2,500 Reduced 11.27%
19,682 Common Stock
Aug 04 2022
SELL
Open market or private sale
$6,496,330 $621.48 p/Share
10,453 Reduced 34.69%
19,682 Common Stock
Aug 04 2022
BUY
Exercise of conversion of derivative security
$4,312,699 $412.58 p/Share
10,453 Added 33.14%
21,092 Common Stock
May 02 2022
SELL
Open market or private sale
$65,058 $650.58 p/Share
100 Reduced 0.45%
22,182 Common Stock
Apr 01 2022
SELL
Open market or private sale
$69,317 $693.17 p/Share
100 Reduced 0.45%
22,282 Common Stock
Mar 01 2022
SELL
Open market or private sale
$61,547 $615.47 p/Share
100 Reduced 0.44%
22,382 Common Stock
Feb 01 2022
SELL
Open market or private sale
$60,604 $606.04 p/Share
100 Reduced 0.44%
22,482 Common Stock
Jan 03 2022
SELL
Open market or private sale
$62,507 $625.07 p/Share
100 Reduced 0.44%
22,391 Common Stock
Jan 03 2022
BUY
Grant, award, or other acquisition
-
191 Added 0.84%
22,582 Common Stock
Dec 01 2021
SELL
Open market or private sale
$63,648 $636.48 p/Share
100 Reduced 0.44%
22,491 Common Stock
Nov 16 2021
SELL
Bona fide gift
-
500 Reduced 2.17%
22,591 Common Stock
Nov 01 2021
SELL
Open market or private sale
$64,292 $642.92 p/Share
100 Reduced 0.43%
23,091 Common Stock
Oct 01 2021
SELL
Open market or private sale
$56,944 $569.44 p/Share
100 Reduced 0.43%
23,191 Common Stock
Sep 01 2021
SELL
Open market or private sale
$67,855 $678.55 p/Share
100 Reduced 0.43%
23,291 Common Stock
Aug 02 2021
SELL
Open market or private sale
$57,648 $576.48 p/Share
100 Reduced 0.43%
23,391 Common Stock
Jul 01 2021
SELL
Open market or private sale
$56,235 $562.35 p/Share
100 Reduced 0.42%
23,491 Common Stock
Jun 14 2021
SELL
Open market or private sale
$52,551 $525.51 p/Share
100 Reduced 0.42%
23,591 Common Stock
Feb 01 2021
SELL
Open market or private sale
$50,782 $507.82 p/Share
100 Reduced 0.42%
23,691 Common Stock
Jan 04 2021
SELL
Open market or private sale
$48,454 $484.54 p/Share
100 Reduced 0.42%
23,543 Common Stock
Jan 04 2021
BUY
Grant, award, or other acquisition
-
248 Added 1.03%
23,791 Common Stock
Dec 01 2020
SELL
Open market or private sale
$52,000 $520.0 p/Share
100 Reduced 0.42%
23,643 Common Stock
Nov 02 2020
SELL
Open market or private sale
$54,892 $548.92 p/Share
100 Reduced 0.42%
23,743 Common Stock
Oct 01 2020
SELL
Open market or private sale
$55,951 $559.51 p/Share
100 Reduced 0.35%
28,343 Common Stock

Also insider at

CFG
CITIZENS FINANCIAL GROUP INC Financial Services
Director
AFR

Arthur F Ryan

Director
Tarrytown, NY

Track Institutional and Insider Activities on REGN

Follow REGENERON PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REGN shares.

Notify only if

Insider Trading

Get notified when an Regeneron Pharmaceuticals, Inc. insider buys or sells REGN shares.

Notify only if

News

Receive news related to REGENERON PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on REGN